BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38361759)

  • 21. Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: Bioinformatics modeling with experimental verification.
    Jia Z; Fu Z; Kong Y; Wang C; Zhou B; Lin Y; Huang Y
    Transl Oncol; 2023 Dec; 38():101774. PubMed ID: 37708719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low
    Xie Z; Chen N
    Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
    Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
    Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 34. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
    Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
    Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma.
    Wen CY; Hsiao JH; Tzeng YT; Chang R; Tsang YL; Kuo CH; Li CJ
    Aging (Albany NY); 2023 Oct; 15(20):11298-11312. PubMed ID: 37847178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
    Chen L; Xiang Z; Chen X; Zhu X; Peng X
    Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
    Sun J; Zhang X; Wu F; Zhu B; Xie H
    BMC Urol; 2024 Apr; 24(1):84. PubMed ID: 38600527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.